Study in Participants With Homozygous Familial Hypercholesterolemia (HoFH)
Clinical trial NCT03156621 · COMPLETED
Trial details
- NCT number
- NCT03156621
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-03
- Primary completion
- 2019-09-27
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.